ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,677, issued on April 14, was assigned to Northwestern University (Evanston, Ill.).
"Targeted PH sensitive liposomes" was invented by Leo I. Gordon (Winnetka, Ill.), Dong-Hyun Kim (Evanston, Ill.), Shuo Yang (Lisle, Ill.), Wooram Park (Evanston, Ill.) and Taehoon Sim (Evanston, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are synthetic nanoparticles, pharmaceutical compositions, kits, or methods for treating and/or preventing cancer. In some embodiments, the synthetic nanoparticles and/or pharmaceutical compositions comprises a pH sensitive liposome, an apolipoprotein, andrographolide or derivative thereof. In some embodiment...